AORT
Price
$43.81
Change
+$0.07 (+0.16%)
Updated
Aug 28, 04:59 PM (EDT)
Capitalization
2.07B
63 days until earnings call
LMAT
Price
$95.13
Change
-$0.55 (-0.57%)
Updated
Aug 28, 04:59 PM (EDT)
Capitalization
2.16B
63 days until earnings call
Interact to see
Advertisement

AORT vs LMAT

Header iconAORT vs LMAT Comparison
Open Charts AORT vs LMATBanner chart's image
Artivion
Price$43.81
Change+$0.07 (+0.16%)
Volume$2.09K
Capitalization2.07B
LeMaitre Vascular
Price$95.13
Change-$0.55 (-0.57%)
Volume$4.46K
Capitalization2.16B
AORT vs LMAT Comparison Chart in %
Loading...
AORT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LMAT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AORT vs. LMAT commentary
Aug 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AORT is a Buy and LMAT is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 29, 2025
Stock price -- (AORT: $43.74 vs. LMAT: $95.68)
Brand notoriety: AORT and LMAT are both not notable
AORT represents the Medical/Nursing Services, while LMAT is part of the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: AORT: 96% vs. LMAT: 83%
Market capitalization -- AORT: $2.07B vs. LMAT: $2.16B
AORT [@Medical/Nursing Services] is valued at $2.07B. LMAT’s [@Pharmaceuticals: Other] market capitalization is $2.16B. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $228.64B to $0. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $169.86B to $0. The average market capitalization across the [@Medical/Nursing Services] industry is $5.65B. The average market capitalization across the [@Pharmaceuticals: Other] industry is $10.96B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AORT’s FA Score shows that 0 FA rating(s) are green whileLMAT’s FA Score has 1 green FA rating(s).

  • AORT’s FA Score: 0 green, 5 red.
  • LMAT’s FA Score: 1 green, 4 red.
According to our system of comparison, LMAT is a better buy in the long-term than AORT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AORT’s TA Score shows that 4 TA indicator(s) are bullish while LMAT’s TA Score has 4 bullish TA indicator(s).

  • AORT’s TA Score: 4 bullish, 4 bearish.
  • LMAT’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, AORT is a better buy in the short-term than LMAT.

Price Growth

AORT (@Medical/Nursing Services) experienced а +1.67% price change this week, while LMAT (@Pharmaceuticals: Other) price change was -0.86% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +2.84%. For the same industry, the average monthly price growth was +5.44%, and the average quarterly price growth was +9.90%.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +4.19%. For the same industry, the average monthly price growth was +5.15%, and the average quarterly price growth was +21.40%.

Reported Earning Dates

AORT is expected to report earnings on Oct 30, 2025.

LMAT is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Medical/Nursing Services (+2.84% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

@Pharmaceuticals: Other (+4.19% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LMAT($2.16B) and AORT($2.07B) have the same market capitalization . AORT YTD gains are higher at: 52.991 vs. LMAT (4.565). LMAT has higher annual earnings (EBITDA): 73.8M vs. AORT (39.8M). LMAT has less debt than AORT: LMAT (185M) vs AORT (264M). AORT has higher revenues than LMAT: AORT (405M) vs LMAT (235M).
AORTLMATAORT / LMAT
Capitalization2.07B2.16B96%
EBITDA39.8M73.8M54%
Gain YTD52.9914.5651,161%
P/E RatioN/A46.47-
Revenue405M235M172%
Total Cash53.5MN/A-
Total Debt264M185M143%
FUNDAMENTALS RATINGS
AORT vs LMAT: Fundamental Ratings
AORT
LMAT
OUTLOOK RATING
1..100
2621
VALUATION
overvalued / fair valued / undervalued
1..100
98
Overvalued
62
Fair valued
PROFIT vs RISK RATING
1..100
4117
SMR RATING
1..100
9356
PRICE GROWTH RATING
1..100
3646
P/E GROWTH RATING
1..100
7867
SEASONALITY SCORE
1..100
9049

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

LMAT's Valuation (62) in the Medical Specialties industry is somewhat better than the same rating for AORT (98). This means that LMAT’s stock grew somewhat faster than AORT’s over the last 12 months.

LMAT's Profit vs Risk Rating (17) in the Medical Specialties industry is in the same range as AORT (41). This means that LMAT’s stock grew similarly to AORT’s over the last 12 months.

LMAT's SMR Rating (56) in the Medical Specialties industry is somewhat better than the same rating for AORT (93). This means that LMAT’s stock grew somewhat faster than AORT’s over the last 12 months.

AORT's Price Growth Rating (36) in the Medical Specialties industry is in the same range as LMAT (46). This means that AORT’s stock grew similarly to LMAT’s over the last 12 months.

LMAT's P/E Growth Rating (67) in the Medical Specialties industry is in the same range as AORT (78). This means that LMAT’s stock grew similarly to AORT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AORTLMAT
RSI
ODDS (%)
Bearish Trend 2 days ago
62%
Bearish Trend 2 days ago
71%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
73%
Bearish Trend 2 days ago
57%
Momentum
ODDS (%)
Bullish Trend 2 days ago
72%
Bullish Trend 2 days ago
77%
MACD
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
59%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
75%
Bearish Trend 2 days ago
57%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
69%
Advances
ODDS (%)
Bullish Trend 7 days ago
75%
Bullish Trend 9 days ago
73%
Declines
ODDS (%)
Bearish Trend 14 days ago
66%
Bearish Trend 3 days ago
54%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
63%
Bearish Trend 2 days ago
61%
Aroon
ODDS (%)
Bullish Trend 2 days ago
77%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
AORT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LMAT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
EPSRX24.620.08
+0.33%
NYLI Epoch Global Equity Yield Class R6
PJRCX8.85N/A
N/A
PGIM Quant Solutions International Eq C
JMGMX56.47N/A
N/A
JPMorgan Mid Cap Growth R6
FIKYX13.88N/A
N/A
Fidelity Advisor Asset Manager 40% Z
WGLSX13.15-0.03
-0.23%
Wasatch Long/Short Alpha Institutional

AORT and

Correlation & Price change

A.I.dvisor indicates that over the last year, AORT has been loosely correlated with TCMD. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if AORT jumps, then TCMD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AORT
1D Price
Change %
AORT100%
-0.66%
TCMD - AORT
43%
Loosely correlated
+1.15%
VREX - AORT
42%
Loosely correlated
+1.51%
LMAT - AORT
42%
Loosely correlated
+0.42%
SONVY - AORT
42%
Loosely correlated
+0.33%
SYK - AORT
41%
Loosely correlated
-0.30%
More

LMAT and

Correlation & Price change

A.I.dvisor indicates that over the last year, LMAT has been loosely correlated with ITGR. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if LMAT jumps, then ITGR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LMAT
1D Price
Change %
LMAT100%
+0.42%
ITGR - LMAT
48%
Loosely correlated
-0.36%
SYK - LMAT
46%
Loosely correlated
-0.30%
UFPT - LMAT
44%
Loosely correlated
-1.77%
AORT - LMAT
40%
Loosely correlated
-0.66%
RDNT - LMAT
39%
Loosely correlated
+1.02%
More